Histologic tumor growth pattern is significantly associated with disease-related survival in muscle-invasive transitional cell carcinoma of the urinary bladder

Oncology Reports

Volumn 12, Issue 3, 2004, Pages 609-613

  Krüger, Stefan ^a   Noack, Frank ^a   Böhle, Andreas ^a   Feller, Alfred C ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Bladder cancer; Growth pattern; Morphology; Prognosis

Indexed keywords

AGED; ARTICLE; BLADDER TUMOR; CANCER INVASION; CELL DIVISION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; MUSCLE TUMOR; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; TIME; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

AGED; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUSCLE NEOPLASMS; NEOPLASM INVASIVENESS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 7744220314     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.3.609     Document Type: Article

References (12)

1. Jemal A, Thomas A, Murray T and Thun M: Cancer statistics 2002. CA Cancer J Clin 52: 23-47, 2002.
2. Sauter G and Mihatsch MJ: Pussycats and baby tigers: non-invasive (pTa) and minimally invasive (pT1) bladder carcinomas are not the same! J Pathol 185: 339-341, 1998. (Pubitemid 28356011)
3. Kakizoe T, Tobisu K, Takai K, Tanaka Y, Kishi K and Teshima S: Relationship between papillary and nodular transitional cell carcinoma in the human urinary bladder. Cancer Res 48: 2299-2303, 1988.
4. Stein JP and Skinner DG: Results with radical cystectomy for treating bladder cancer: a 'reference standard' for high-grade, invasive bladder cancer. BJU Int 92: 12-17, 2003. (Pubitemid 36843020)
5. Jiminez RE, Gheiler E, Oskanian P, Tiguert R, Sakr W, Wood DP, Pontes JE and Grignon DJ: Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol 24: 980-987, 2000. (Pubitemid 30430485)
6. Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA and Marberger M: Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. J Urol 165: 1281-1287, 2001.
7. Hermanek P, Hutter RVP, Sobin LH, Wagner G and Wittekind C (eds): TNM Atlas. Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours. Springer Verlag, Berlin, pp309-314, 1997.
8. Epstein JI, Amin MB, Reuter VR, Mostofi FK and Bladder Consensus Conference Committee: The World Health Organization/International Socieaty of Urologicai Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 22: 1435-1448, 1998.
9. Korkolopoulou P, Lazaris AC, Konstantinidou AE, Kavantzas N, Pathsouris E, Christodoulou P, Thomas-Tsagli E and Davaris P: Differential expression of bcl-2 family proteins in bladder carcinomas. Relationship with apoptotic rate and survival. Eur Urol 41: 274-283, 2002. (Pubitemid 35303425)
10. Schmitz-Dräger BJ, Goebell PJ and Heydthausen M: p53 immunohistochemistry in bladder cancer. Combined analysis: a way to go? Urol Oncol 5: 204-210, 2000.
11. Gao JP, Uchida T, Wang C, Jiang SX, Matsumoto K, Satoh T, Minei S, Soh S, Kameya T and Baba S: Relationship between p53 gene mutation and protein expression: clinical significance in transitional cell carcinoma of the bladder. Int J Oncol 16: 469-475, 2000.
12. Cheng L, Neumann RM, Nehra A, Spotts BE, Weaver AL and Bostwick DG: Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. Cancer 88: 1663-1670, 2000. (Pubitemid 30183152)